跳至主要内容
临床试验/NCT05195515
NCT05195515Enrolling By Invitation不适用

The Impact of Late Effects After Treatment for Bladder Cancer on Quality of Life - What is the Cost of the Cure?

Aarhus University Hospital5 个研究点 分布在 1 个国家目标入组 2,000 人开始时间: 2022年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
Enrolling By Invitation
发起方
入组人数
2,000
试验地点
5
主要终点
Health-related Quality of Life

研究概览

简要总结

Bladder Cancer prognosis, treatment, and subsequent morbidity and mortality vary between the different stages, thus resulting in a different impact on patients' lives. There are some well known late effects of the treatments for bladder cancer, but the knowledge of their impact on patients Quality of Life is sparse. This study aims to determine the prevalence of late effects impact on Quality of Life and potential risk factors for impairment.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients are eligible if they are referred to a hospital in the Central Region Denmark, due to hematuria between 01/01/2022 and 01/01/2023
  • Ability to understand written and oral Danish

排除标准

  • Known Alzheimers disease
  • Diagnosed other causes explaining the hematuria

结局指标

主要结局

Health-related Quality of Life

时间窗: 5 years from baseline inclusion

Changes in Quality of Life measured using validated instruments

次要结局

  • Prevalence of late effects(5 years from baseline inclusion)

研究者

发起方
Aarhus University Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jørgen Bjerggaard Jensen

Professor, DMSc

Aarhus University Hospital

研究点 (5)

Loading locations...

相似试验